Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
Condition(s):Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic LeukemiaLast Updated:August 7, 2018Withdrawn
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic LeukemiaLast Updated:August 7, 2018Withdrawn
Condition(s):Wegener’s Granulomatosis or Microscopic PolyangiitisLast Updated:July 6, 2022Completed
Condition(s):Idiopathic Nephrotic Syndrome; Minimal Change Disease; Focal Segmental GlomerulosclerosisLast Updated:August 27, 2018Unknown status
Condition(s):Myocarditis; Giant Cell MyocarditisLast Updated:September 9, 2010Completed
Condition(s):HemangiomaLast Updated:June 11, 2013Terminated
Condition(s):Rheumatoid ArthritisLast Updated:October 18, 2023Recruiting
Condition(s):Articular Cartilage Disorder of KneeLast Updated:March 20, 2024Withdrawn
Condition(s):Steroid-Sensitive Nephrotic SyndromeLast Updated:December 17, 2020Withdrawn
Condition(s):Erythema MultiformeLast Updated:February 20, 2024Not yet recruiting
Condition(s):IgA NephropathyLast Updated:June 4, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.